person

Lysiane M.

Country
France
Department
Clinical Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
86
Sites with multiple studies

Has run more than one trial at 86 of 233 partner sites.

Specializations

Lymphoma Research

The investigator specializes in treating various forms of lymphoma, with particular focus on diffuse large B-cell lymphoma (DLBCL) and classical Hodgkin lymphoma. Their research encompasses both newly diagnosed and relapsed/refractory cases.

  • First-line DLBCL treatments
  • Advanced classical Hodgkin lymphoma therapy
  • Novel combination therapies

Work includes evaluating innovative therapeutic combinations incorporating targeted agents like polatuzumab vedotin and brentuximab vedotin.

Leukemia Studies

Focuses on advancing treatment options for Chronic Lymphocytic Leukemia (CLL), with particular attention to elderly patients and those with coexisting medical conditions.

  • High-risk CLL management
  • Targeted therapy approaches
  • Age-specific treatment strategies

Investigates novel therapeutic agents including venetoclax, obinutuzumab, and acalabrutinib for CLL treatment.

Therapeutic Innovation

Explores cutting-edge treatment combinations incorporating immunotherapy and targeted therapeutic approaches for hematologic malignancies.

  • Combination therapy development
  • Treatment optimization studies
  • Progressive disease management

Evaluates treatment efficacy through progression-free survival outcomes across various therapeutic regimens.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.